Xtandi - 40 mg soft capsules, Xofigo 1100 kBq/mL solution for injection
Phase 3 small_molecule active
Quick answer
Xtandi - 40 mg soft capsules, Xofigo 1100 kBq/mL solution for injection for Castration resistant prostate cancer patients metastatic to bone. is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Castration resistant prostate cancer patients metastatic to bone.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active